One stock that we have continued to cheer on through corrections and ranges, with a firm belief in eventual leadership status and success, is OrganiGram Holdings Inc (OTCMKTS:OGRMF). This is the next logical choice behind APHA, ACB, and CGC when it comes to the big Canadian production plays in the cannabis patch. Shares of OGRMF just broke out to new all-time once again in March, and now we face the question of whether that breakout will hold. Our bias on this one remains intact. To further flesh out the story, the company just announced an update on its previously announced mandatory conversion of the Company’s 6.0% convertible unsecured debentures due January 31, 2020.

According to the release, “As announced on February 27, 2019, the Company elected to exercise its right under the Debenture Indenture between the Company and the TSX Trust Company dated as of January 31, 2018 governing the Debentures, to convert all of the principal amount outstanding of the remaining Debentures on April 1, 2019 into common shares of the Company.”

OrganiGram Holdings Inc (OTCMKTS:OGRMF) casts itself as a company that produces and sells medical marijuana to individuals and physicians in Canada. It offers marijuana plants, seeds, and cuttings; cannabis oil; and dried flower and cannabis.

The company sells its products through phone and online store. It also operates healing centers that offer treatments for post-traumatic stress disorders, chronic pain, and trauma therapy. In addition, the company exports its products.

OrganiGram Holdings Inc. was founded in 2013 and is based in Moncton, Canada.

Moreover, OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition-specific medical marijuana for patients in Canada.

OGRMF’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.

According to company materials, “From the day we started back in 2013, it’s been about making lives better – for our clients, our people, and our community. We’re based in Moncton, New Brunswick, the heart of the Maritimes, but at OrganiGram Holdings we’re committed to improving the quality of life for Canadians across the country. For us, this means working with health-care providers and industry organizations, supporting research and education, and providing a safe, effective product. To be effective in that last goal, we made a decision to produce organic cannabis. Growing certified organic medical cannabis isn’t easy, in fact, most licensed producers won’t take this on. It means more care, more testing, more rules… but in the end, it means a product that we feel delivers on our goals in the best way. And improving the quality of life for Canadians is not just about getting safe, quality product to them effectively. It’s about creating jobs, being good neighbors and contributing to our community.”

As noted above, OGRMF just announced an update on its previously announced mandatory conversion of the Company’s 6.0% convertible unsecured debentures due January 31, 2020.

Recent action has seen 4% piled on for shareholders of the company during the trailing month. Moreover, the name has registered increased average transaction volume recently, with the past month seeing 17% beyond what we have been seeing over the larger time frame.

According to the release, “Pursuant to the terms of the Indenture, the Company may force the conversion of the aggregate principal amount of the outstanding Debentures at the conversion price of $5.42 per Common Share when the daily volume weighted average trading price of the Common Shares on the Exchange (“VWAP”) for 10 consecutive trading days exceeds $7.05. As of the close of markets on February 26, 2019, the VWAP exceeded $7.05 for 10 consecutive trading days. The Company provided the holders of the Debentures with at least 30 days advance written notice of the Conversion.”